CTLA4 and Miyoshi myopathy: Higher levels of Treg-associated markers, including CTLA-4, glucocorticoid-induced tumor necrosis factor receptor (GITR), and OX40, have been seen in the peripheral blood of MM patients, which may improve their suppressive function [39].